Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Martins

Showing results (241-250 of 313) with videos related to

Pageof 32
Sort By:
Kidney & Blood Pressure Research|January 27, 2022
Growth Differentiation Factor-15 and Syndecan-1 Are Potential Biomarkers of Cardiac and Renal Involvement in Classical Fabry Disease under Enzyme Replacement TherapyPaulo C Gregório, Gilson Biagini, Regiane S da Cunha, et al.
JIMD Reports|February 12, 2014
Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients Under 1 Year of AgeChristina Lampe, Andrea Atherton, Barbara K Burton, et al.
Pharmaceutical Biology|November 15, 2011
Bioactive compounds from endemic plants of Southwest Portugal: inhibition of acetylcholinesterase and radical scavenging activitiesLucélia Tavares, Sofia Fortalezas, Meenu Tyagi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2024
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trialPaul Harmatz, Roberto Giugliani, Ana Maria Martins, et al.
Orphanet Journal of Rare Diseases|October 9, 2015
Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibshipsNouriya A Al-Sannaa, Luisa Bay, Deborah S Barbouth, et al.
Journal of Bodywork and Movement Therapies|November 27, 2024
Is a 12-week home-based functional teletraining for individuals with type 2 diabetes an alternative for blood glucose control?Denise Maria Martins Vancea, Thiago Borges Madureira Sabino, Jonathan Nicolas Dos Santos Ribeiro, et al.
Ciencia & Saude Coletiva|December 8, 2016
[Leptospirosis space-time distribution and risk factors in Belém, Pará, Brazil]Nelson Veiga Gonçalves, Ediane Nunes de Araujo, Alcinês da Silva Sousa, et al.
Genetics and Molecular Biology|July 30, 2014
Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin AmericaRoberto Giugliani, Martha Luz Solano Villarreal, C Araceli Arellano Valdez, et al.
Muscles (Basel, Switzerland)|August 4, 2025
W Prime: Evidence-Based Proposal for a New Predictor of Gait Speed in Older WomenGersiel Nascimento de Oliveira Júnior, Jairo de Freitas Rodrigues de Sousa, Marcelo Augusto da Silva Carneiro, et al.
Journal of Fungi (Basel, Switzerland)|January 24, 2025
Azole Resistance and <i>ERG11</i> Mutation in Clinical Isolates of <i>Candida tropicalis</i>Adriele Celine Siqueira, Gisele Aparecida Bernardi, Lavinia Nery Villa Stangler Arend, et al.
Pageof 32

Showing results (241-250 of 313) with videos related to

Sort By:
Pageof 32
Kidney & Blood Pressure Research|January 27, 2022
Growth Differentiation Factor-15 and Syndecan-1 Are Potential Biomarkers of Cardiac and Renal Involvement in Classical Fabry Disease under Enzyme Replacement TherapyPaulo C Gregório, Gilson Biagini, Regiane S da Cunha, et al.
JIMD Reports|February 12, 2014
Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients Under 1 Year of AgeChristina Lampe, Andrea Atherton, Barbara K Burton, et al.
Pharmaceutical Biology|November 15, 2011
Bioactive compounds from endemic plants of Southwest Portugal: inhibition of acetylcholinesterase and radical scavenging activitiesLucélia Tavares, Sofia Fortalezas, Meenu Tyagi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2024
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trialPaul Harmatz, Roberto Giugliani, Ana Maria Martins, et al.
Orphanet Journal of Rare Diseases|October 9, 2015
Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibshipsNouriya A Al-Sannaa, Luisa Bay, Deborah S Barbouth, et al.
Journal of Bodywork and Movement Therapies|November 27, 2024
Is a 12-week home-based functional teletraining for individuals with type 2 diabetes an alternative for blood glucose control?Denise Maria Martins Vancea, Thiago Borges Madureira Sabino, Jonathan Nicolas Dos Santos Ribeiro, et al.
Ciencia & Saude Coletiva|December 8, 2016
[Leptospirosis space-time distribution and risk factors in Belém, Pará, Brazil]Nelson Veiga Gonçalves, Ediane Nunes de Araujo, Alcinês da Silva Sousa, et al.
Genetics and Molecular Biology|July 30, 2014
Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin AmericaRoberto Giugliani, Martha Luz Solano Villarreal, C Araceli Arellano Valdez, et al.
Muscles (Basel, Switzerland)|August 4, 2025
W Prime: Evidence-Based Proposal for a New Predictor of Gait Speed in Older WomenGersiel Nascimento de Oliveira Júnior, Jairo de Freitas Rodrigues de Sousa, Marcelo Augusto da Silva Carneiro, et al.
Journal of Fungi (Basel, Switzerland)|January 24, 2025
Azole Resistance and <i>ERG11</i> Mutation in Clinical Isolates of <i>Candida tropicalis</i>Adriele Celine Siqueira, Gisele Aparecida Bernardi, Lavinia Nery Villa Stangler Arend, et al.
Pageof 32